GRWD1 as a Novel Signature and It Down Regulates IFN in Skin Aging
Cell Biochemistry and Function · 2026-07 · 44 (7)
DOI: 10.1002/cbf.70258 ↗At a glance
Journal article in Cell Biochemistry and Function, published online on 2026-07-13. Written by Fei Tan and 9 co-authors. Institution: Shanghai Skin Disease Hospital, School of Medicine, Tongji University, Shanghai, China. Major MEDLINE topics: Skin Aging, Interferons, Down-Regulation. 44 references. The full text is freely available in PubMed Central. Funded by: The Shanghai Shen Kang Clinical Technology Promotion Program (No. SHDC12026111) and The Xi'an Municipal Health Commission General Research Project (No. 2026ms0….
Abstract (original language)
Deep mining of the molecular mechanisms underlying skin aging is critical for the development of novel therapeutic targets. The aim of this study was to explore potential key signatures and underlying mechanisms in skin aging. Bioinformatics tools were used to evaluate the differentially expressed genes (DEGs), perform enrichment analysis, and construct protein‐protein interaction networks on datasets. The hub genes were identified using Cytoscape software and then confirmed by qRT‐PCR and Western Blot in vitro. We focused on the possible roles of GRWD1. GRWD1 expression were suppressed in senescence model of HDF. After GRWD1 overexpression by lentivirus in primary human dermal Fibroblasts (HDF), transcriptome sequencing (RNA‐seq) was performed. GRWD1 has influence on the inflammation and immune responses. IFN signaling pathway genes significant increase in senescence HDF. When GRWD1 overexpressed, decreased expression of IFN pathway is validated. Besides, age‐related markers p16, IL‐6, and IL‐8 expression decreased and Lamin B expression also increased. It was also proved after GRWD1 knockdown. GRWD1 was identified as a novel signature in skin aging. GRWD1 directly interact with IRF3. GRWD1 overexpression can down regulate IFN signaling pathway key genes expression, further diminish IFN aging‐inducing effects. GRWD1 alleviates skin inflammatory responses by suppressing IRF3‐mediated IFN pathway activation. Our findings suggest that GRWD1 may serve as a molecular biomarker and further as a potential therapeutic target for skin aging.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Shanghai Skin Disease Hospital, School of Medicine, Tongji University, Shanghai, China.
- Shanghai Skin Disease Clinical College, The Fifth Clinical Medical College, Anhui Medical University, Shanghai Skin Disease Hospital, Shanghai, China.
- Department of Ophthalmology of Tongji Hospital and Laboratory of Clinical and Visual Sciences of Tongji Eye Institute, School of Medicine, Tongji University, Shanghai, China.
- Department of General Practice, Xi'an Central Hospital, Xi'an, China.
- School of Public Health and General Medicine, and Department of Cell Biology and Medical Genetics, School of Medicine, Tongji University, Shanghai, China.
ORCID profiles: Juan Wang
Funding
- The Shanghai Shen Kang Clinical Technology Promotion Program (No. SHDC12026111) and The Xi'an Municipal Health Commission General Research Project (No. 2026ms0…
Cite
APA
Tan, F., Wang, Y., Xu, P., Li, Y., Yan, Y., Gao, Y., Hu, X., Shen, M., Wang, Q., & Wang, J. (2026). GRWD1 as a Novel Signature and It Down Regulates IFN in Skin Aging. Cell Biochemistry and Function, 44(7). https://doi.org/10.1002/cbf.70258
Vancouver
Tan F, Wang Y, Xu P, Li Y, Yan Y, Gao Y, et al. GRWD1 as a Novel Signature and It Down Regulates IFN in Skin Aging. Cell Biochemistry and Function. 2026;44(7). doi:10.1002/cbf.70258
BibTeX
@article{Tan2026,
author = {Tan, Fei and Wang, Yaoqun and Xu, Peng and Li, Yunjin and Yan, Yichen and Gao, Yutong and Hu, Xiaoping and Shen, Mengyuan and Wang, Qixia and Wang, Juan},
title = {GRWD1 as a Novel Signature and It Down Regulates IFN in Skin Aging},
journal = {Cell Biochemistry and Function},
year = {2026},
volume = {44},
number = {7},
doi = {10.1002/cbf.70258}
}
EUVIMED